Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Mini Review
  • Published:

Mini-Review

Extracorporeal photopheresis in chronic graft-versus-host disease

Abstract

Despite significant advances in stem cell manipulation and post-transplant immunosuppression, chronic graft-versus-host disease (cGVHD) remains a cause of major long-term morbidity in survivors of allogeneic stem cell transplantation. Extracorporeal photopheresis (ECP) is a novel therapeutic intervention which has demonstrated efficacy in patients with refractory acute and chronic GVHD. Clinical responses have been reported in skin and visceral GVHD. While the long-term immunomodulatory effects of ECP in cGVHD are unknown, recent studies of patients undergoing a 6- to 12-month course of ECP treatment demonstrated an attenuation of Th1-mediated cytokine secretion by activated T-helper cells, a shift in the DC1/DC2 ratio favoring plasmacytoid rather than monocytoid dendritic cell profiles, and a decrease in antigen responsiveness by dendritic cells. The implications of these immunomodulatory effects of ECP on pathogenesis and clinical outcome remains a fertile area for future research.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Remberger M, Ringden O, Blau IW et al. No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors Blood 2001 98: 1739 1745

    Article  CAS  PubMed  Google Scholar 

  2. Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies Transplantation 1991 51: 443 447

    Article  CAS  PubMed  Google Scholar 

  3. Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease Blood 1997 90: 4705 4709

    CAS  PubMed  Google Scholar 

  4. Gaziev D, Polchi P, Galimberti M et al. Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors Transplantation 1997 63: 854 860

    Article  CAS  PubMed  Google Scholar 

  5. Lazarus HM, Rowe JM . New and experimental therapies for treating graft-versus-host disease Blood Rev 1995 9: 117 133

    Article  CAS  PubMed  Google Scholar 

  6. Urbano-Ispizua A, Garcia-Conde J, Brunet S et al. High incidence of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT Haematologica 1997 82: 683 689

    CAS  PubMed  Google Scholar 

  7. Ratanatharathorn V, Ayash L, Lazarus HM et al. Chronic graft-versus-host disease: clinical manifestation and therapy Bone Marrow Transplant 2001 28: 121 129

    Article  CAS  PubMed  Google Scholar 

  8. Vogelsang GB . How I treat chronic graft-versus-host disease Blood 2001 97: 1196 1201

    Article  CAS  PubMed  Google Scholar 

  9. Shulman HM, Sale GE, Lerner KG et al. Chronic cutaneous graft-versus-host disease in man Am J Pathol 1978 91: 545 570

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Eppinger T, Ehninger G, Steinert M et al. 8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease Transplantation 1990 50: 807 811

    Article  CAS  PubMed  Google Scholar 

  11. Aubin F, Brion A, Deconinck E et al. Phototherapy in the treatment of cutaneous graft-versus-host disease. Our preliminary experience in resistant patients Transplantation 1995 59: 151 155

    Article  CAS  PubMed  Google Scholar 

  12. Jampel RM, Farmer ER, Vogelsang GB et al. PUVA therapy for chronic cutaneous graft-vs-host disease Arch Dermatol 1991 127: 1673 1678

    Article  CAS  PubMed  Google Scholar 

  13. Vogelsang GB, Wolff D, Altomonte V et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA) Bone Marrow Transplant 1996 17: 1061 1067

    CAS  PubMed  Google Scholar 

  14. Basara N, Gunzelmann S, Willenbacher W et al. New immunosuppressants in BMT/GVHD Transplant Proc 2001 33: 2220 2222

    Article  CAS  PubMed  Google Scholar 

  15. Simpson D . Drug therapy for acute graft-versus-host disease prophylaxis J Hematother Stem Cell Res 2000 9: 317 325

    Article  CAS  PubMed  Google Scholar 

  16. Przepiorka D, Kernan NA, Ippoliti C et al. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease Blood 2000 95: 83 89

    CAS  PubMed  Google Scholar 

  17. Vogelsang GB, Farmer ER, Hess AD et al. Thalidomide for the treatment of chronic graft-versus-host disease New Engl J Med 1992 326: 1055 1058

    Article  CAS  PubMed  Google Scholar 

  18. Bladon J, Taylor PC . Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients Br J Haematol 1999 107: 707 711

    Article  CAS  PubMed  Google Scholar 

  19. Edelson R, Berger C, Gasparro F et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results New Engl J Med 1987 316: 297 303

    Article  CAS  PubMed  Google Scholar 

  20. Lim HW, Edelson RL . Photopheresis for the treatment of cutaneous T-cell lymphoma Hematol Oncol Clin North Am 1995 9: 1117 1126

    Article  CAS  PubMed  Google Scholar 

  21. Wolfe JT, Lessin SR, Singh AH, Rook AH . Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection Artif Organs 1994 18: 888 897

    Article  CAS  PubMed  Google Scholar 

  22. Rook AH, Wolfe JT . Role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection J Clin Apheresis 1994 9: 28 30

    Article  CAS  PubMed  Google Scholar 

  23. Rook AH, Suchin KR, Kao DM et al. Photopheresis: clinical applications and mechanism of action J Invest Dermatol Symp Proc 1999 4: 85 90

    Article  CAS  Google Scholar 

  24. Rook AH, Freundlich B, Jegasothy BV et al. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial Arch Dermatol 1992 128: 337 346

    Article  CAS  PubMed  Google Scholar 

  25. Malawista SE, Trock D, Edelson RL . Photopheresis for rheumatoid arthritis Ann NY Acad Sci 1991 636: 217 226

    Article  CAS  PubMed  Google Scholar 

  26. Barr ML, Meiser BM, Eisen HJ et al. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group New Engl J Med 1998 339: 1744 1751

    Article  CAS  PubMed  Google Scholar 

  27. Wieland M, Thiede VL, Strauss RG et al. Treatment of severe cardiac allograft rejection with extracorporeal photochemotherapy J Clin Apheresis 1994 9: 171 175

    Article  CAS  PubMed  Google Scholar 

  28. Wolfe JT, Tomaszewski JE, Grossman RA et al. Reversal of acute renal allograft rejection by extracorporeal photopheresis: a case presentation and review of the literature J Clin Apheresis 1996 11: 36 41

    Article  CAS  PubMed  Google Scholar 

  29. Ullrich SE . Photoinactivation of T-cell function with psoralen and UVA radiation suppresses the induction of experimental murine graft-versus-host disease across major histocompatibility barriers J Invest Dermatol 1991 96: 303 308

    Article  CAS  PubMed  Google Scholar 

  30. Girardi M, Herreid P, Tigelaar RE . Specific suppression of lupus-like graft-versus-host disease using extracorporeal photochemical attenuation of effector lymphocytes J Invest Dermatol 1995 104: 177 182

    Article  CAS  PubMed  Google Scholar 

  31. Marks DI, Iannoni B, Coote MA et al. Prevention of cyclophosphamide-induced and spontaneous diabetes in NOD mice by syngeneic splenocytes treated with cytotoxic drugs Autoimmunity 1991 11: 73 79

    Article  CAS  PubMed  Google Scholar 

  32. Yoo EK, Rook AH, Elenitsas R et al. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action J Invest Dermatol 1996 107: 235 242

    Article  CAS  PubMed  Google Scholar 

  33. Tambur AR, Ortegel JW, Morales A et al. Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis Transplant Proc 2000 32: 747 748

    Article  CAS  PubMed  Google Scholar 

  34. Zouboulis CC, Schmuth M, Doepfmer S et al. Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes Dermatology 1998 196: 305 308

    Article  CAS  PubMed  Google Scholar 

  35. Di Renzo M, Rubegni P, De Aloe G et al. Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma Immunology 1997 92: 99 103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Vowels BR, Cassin M, Boufal MH et al. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis J Invest Dermatol 1992 98: 686 692

    Article  CAS  PubMed  Google Scholar 

  37. Berger CL, Xu AL, Hanlon D et al. Induction of human tumor-loaded dendritic cells Int J Cancer 2001 91: 438 447

    Article  CAS  PubMed  Google Scholar 

  38. Edelson RL . Photopheresis: a clinically relevant immunobiologic response modifier Ann NY Acad Sci 1991 636: 154 164

    Article  CAS  PubMed  Google Scholar 

  39. Owsianowski M, Gollnick H, Siegert W et al. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis Bone Marrow Transplant 1994 14: 845 848

    CAS  PubMed  Google Scholar 

  40. Rossetti F, Zulian F, Dall'Amico R et al. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease Transplantation 1995 59: 149 151

    Article  CAS  PubMed  Google Scholar 

  41. Rossetti F, Dall'Amico R, Crovetti G et al. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease Bone Marrow Transplant 1996 18: (Suppl. 2) 175 181

    PubMed  Google Scholar 

  42. Dall'Amico R, Rossetti F, Zulian F et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease Br J Haematol 1997 97: 848 854

    Article  CAS  PubMed  Google Scholar 

  43. Abhyankar S, Godder K, Chiang K et al. Extracorporeal photopheresis with UVADEX for the treatment of chronic graft-versus-host disease Exp Hematol 1998 26: 32

    Google Scholar 

  44. Child FJ, Ratnavel R, Watkins P et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD) Bone Marrow Transplant 1999 23: 881 887

    Article  CAS  PubMed  Google Scholar 

  45. Greinix HT, Volc-Platzer B, Rabitsch W et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease Blood 1998 92: 3098 3104

    CAS  PubMed  Google Scholar 

  46. Greinix HT, Volc-Platzer B, Kalhs P et al. Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study Blood 2000 96: 2426 2431

    CAS  PubMed  Google Scholar 

  47. Nestel FP, Price KS, Seemayer TA, Lapp WS . Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease J Exp Med 1992 175: 405 413

    Article  CAS  PubMed  Google Scholar 

  48. Abhyankar S, Gilliland DG, Ferrara JL . Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft-versus-host disease to minor histocompatibility antigens Transplantation 1993 56: 1518 1523

    Article  CAS  PubMed  Google Scholar 

  49. Tanaka J, Imamura M, Kasai M et al. The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease Bone Marrow Transplant 1997 19: 571 576

    Article  CAS  PubMed  Google Scholar 

  50. Fowler DH, Gress RE . Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma Leuk Lymphoma 2000 38: 221 234

    Article  CAS  PubMed  Google Scholar 

  51. Lu Y, Sakamaki S, Kuroda H et al. Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603 Blood 2001 97: 1123 1130

    Article  CAS  PubMed  Google Scholar 

  52. Ferrara JL . Cytokine dysregulation as a mechanism of graft-versus-host disease Curr Opin Immunol 1993 5: 794 799

    Article  CAS  PubMed  Google Scholar 

  53. Korholz D, Kunst D, Hempel L et al. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation Bone Marrow Transplant 1997 19: 691 695

    Article  CAS  PubMed  Google Scholar 

  54. Alcindor T, Gorgun G, Miller KB et al. Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease Blood 2001 98: 1622 1625

    Article  CAS  PubMed  Google Scholar 

  55. Vink AA, Moodycliffe AM, Shreedhar V et al. The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photo-repair of cyclobutane pyrimidine dimers Proc Natl Acad Sci USA 1997 94: 5255 5260

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Shlomchik WD, Couzens MS, Tang CB et al. Prevention of graft-versus-host disease by inactivation of host antigen-presenting cells Science 1999 285: 412 415

    Article  CAS  PubMed  Google Scholar 

  57. Ramsdell F, Seaman MS, Miller RE et al. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death Int Immunol 1994 6: 1545 1553

    Article  CAS  PubMed  Google Scholar 

  58. Chan G, Foss F, Roberts T et al. Decreased acute and chronic GVHD and early full donor engrafment following a pentostatin-based preparative regimen for allogeneic bone marrow transplant in high risk patients Blood 2000 98: 383a

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Foss, F., Gorgun, G. & Miller, K. Extracorporeal photopheresis in chronic graft-versus-host disease. Bone Marrow Transplant 29, 719–725 (2002). https://doi.org/10.1038/sj.bmt.1703529

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703529

Keywords

This article is cited by

Search

Quick links